• FDA rejects oral Type I diabetes drug pharmatimes
    March 27, 2019
    The US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for Sanofi’s type I diabetes drug, Zynquista (sotagliflozin).
  • Sanofi-Lexicon diabetes drug gets split verdict from FDA panel pharmaceutical-technology
    January 21, 2019
    Sanofi and Lexicon Pharmaceuticals have received split decision from an advisory panel to the US Food and Drug Administration (FDA) on whether to recommend diabetes drug Zynquista (sotagliflozin) for approval....
PharmaSources Customer Service